OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 66 filers reported holding OCULAR THERAPEUTIX INC in Q1 2018. The put-call ratio across all filers is 0.56 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,318 | +87.5% | 250 | 0.0% | 0.00% | – |
| Q4 2022 | $703 | -82.4% | 250 | 0.0% | 0.00% | – |
| Q2 2021 | $4,000 | -20.0% | 250 | 0.0% | 0.00% | – |
| Q4 2020 | $5,000 | +150.0% | 250 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 250 | -13.2% | 0.00% | – |
| Q1 2018 | $2,000 | +100.0% | 288 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | -50.0% | 288 | 0.0% | 0.00% | – |
| Q3 2017 | $2,000 | -33.3% | 288 | 0.0% | 0.00% | – |
| Q2 2017 | $3,000 | 0.0% | 288 | 0.0% | 0.00% | – |
| Q1 2017 | $3,000 | 0.0% | 288 | -37.4% | 0.00% | -100.0% |
| Q3 2016 | $3,000 | 0.0% | 460 | -16.2% | 0.00% | 0.0% |
| Q2 2016 | $3,000 | -40.0% | 549 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $5,000 | 0.0% | 549 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $5,000 | – | 549 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,932,607 | $40,643,000 | 15.56% |
| Lamond Capital Partners LLC | 711,533 | $14,964,000 | 15.19% |
| Polaris Venture Management Co. V, L.L.C. | 1,230,009 | $25,867,000 | 11.54% |
| NOTTINGHAM ADVISORS, INC. | 171,985 | $3,617,000 | 0.60% |
| Portolan Capital Management | 122,518 | $2,577,000 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 160,000 | $3,365,000 | 0.33% |
| Rotella Capital Management, Inc. | 18,461 | $388,000 | 0.32% |
| Monashee Investment Management LLC | 28,834 | $606,000 | 0.29% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 335,498 | $7,056,000 | 0.24% |
| BAILARD, INC. | 55,000 | $1,157,000 | 0.18% |